key: cord-0922202-6e3812a7
authors: Carvalho, Henrique Cyrne
title: STEMI na pandemia de COVID-19: um passo para trás numa história de sucesso
date: 2022-02-18
journal: Rev Port Cardiol
DOI: 10.1016/j.repc.2022.02.003
sha: 1957891e31cee8d57eebb003d2b5595cbb5a275e
doc_id: 922202
cord_uid: 6e3812a7

nan

indicated that the reduction in STEMI presentations was over 40%. Approximately 60% of all respondents reported that STEMI patients presented later than usual and 58.5% that more than 40% of STEMI patients admitted to hospital presented beyond the optimal window for primary percutaneous coronary intervention (PPCI) or thrombolysis.

In July 2020, Garcia et al. 4 period than in previous years (1.9% vs. 12.1%).

Taking together the information from multicenter studies published in different continents, we can conclude that during the first Covid-19 wave, there were fewer patients presenting with STEMI at catheterization laboratories, timely access to the cardiac catheterization laboratory for PPCI decreased, door to balloon time increased, and cardiac mortality and mechanical complications probably also

increased.

This is important information, as it is clear that the pandemic is not over. It should be borne in mind that the results described above may evolve, and for this reason health policies should take them into

Management and outcomes of patients with STEMI during the COVID-19 Pandemic in China

STEMI and COVID-19 Pandemic in Saudi Arabia

Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology

Christian Schmidt et al: Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States

Worrisome trends of ST-elevation myocardial infarction during the COVID-19 pandemic